Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Taking high doses of Cyproterone acetate significantly increases the risk of meningioma in females.

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Zinc supplements and diet changes can effectively treat zinc deficiency and prevent complications.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Bimekizumab effectively treats scalp cellulitis and improves quality of life.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Adalimumab improved folliculitis decalvans in most patients.

The serum with microneedling device improves hair loss treatment effectively and safely.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

The serum with microneedling effectively treats alopecia areata by enhancing drug delivery and is safe and patient-friendly.

MSUD patients need careful monitoring of amino acids and zinc to prevent severe symptoms.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

CS12192 effectively treats alopecia areata with better safety than current options.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

Aftimoon (Cuscuta reflexa) has various health benefits, including anti-inflammatory and anticonvulsant effects.

Alefacept showed some effectiveness for alopecia areata but needs more research.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.

Aftimoon has potential health benefits for various diseases and could be integrated into modern healthcare.

Zinc supplementation effectively treats acrodermatitis enteropathica symptoms.

A woman had meningitis caused by mixed connective tissue disease, not an infection.